0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States Cancer Biotherapy Market Report & Forecast 2022-2028
Published Date: June 2022
|
Report Code: QYRE-Auto-18N5929
Home | Market Reports | Health | Health Conditions | Cancer
Global and United States Cancer Biotherapy Market Report Forecast 2022 2028

Global and United States Cancer Biotherapy Market Report & Forecast 2022-2028

Code: QYRE-Auto-18N5929
Report
June 2022
91 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Cancer biotherapy is a form of treatment that uses the natural immune system to protect the body against cancer.
Market Analysis and Insights: Global and United States Cancer Biotherapy Market
This report focuses on global and United States Cancer Biotherapy market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Cancer Biotherapy market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, by Type, Monoclonal Antibodies accounting for % of the Cancer Biotherapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Cancer Biotherapy market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.

Global Cancer Biotherapy Scope and Market Size
Cancer Biotherapy market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cancer Biotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Cancer Biotherapy market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Monoclonal Antibodies
Vaccines
Erythropoietin
Colony Stimulating Factors
Interleukins and Interferons

Segment by Application

Hospitals
Diagnostic Laboratories
Research and Academic Laboratories
Pharmaceutical and Biotechnology Companies
Others

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

BY COMPANY

Amgen
Bristol-Myers Squibb
Celgene
GlaxoSmithKline
Eli Lilly
1 Study Coverage
1.1 Cancer Biotherapy Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million) Introduction
1.2 Global Cancer Biotherapy Outlook 2017 VS 2022 VS 2028
1.2.1 Global Cancer Biotherapy Market Size for the Year 2017-2028
1.2.2 Global Cancer Biotherapy Market Size for the Year 2017-2028
1.3 Cancer Biotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Cancer Biotherapy in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Cancer Biotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Cancer Biotherapy Market Dynamics
1.4.1 Cancer Biotherapy Industry Trends
1.4.2 Cancer Biotherapy Market Drivers
1.4.3 Cancer Biotherapy Market Challenges
1.4.4 Cancer Biotherapy Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Cancer Biotherapy by Type
2.1 Cancer Biotherapy Market Segment by Type
2.1.1 Monoclonal Antibodies
2.1.2 Vaccines
2.1.3 Erythropoietin
2.1.4 Colony Stimulating Factors
2.1.5 Interleukins and Interferons
2.2 Global Cancer Biotherapy Market Size by Type (2017, 2022 & 2028)
2.3 Global Cancer Biotherapy Market Size by Type (2017-2028)
2.4 United States Cancer Biotherapy Market Size by Type (2017, 2022 & 2028)
2.5 United States Cancer Biotherapy Market Size by Type (2017-2028)
3 Cancer Biotherapy by Application
3.1 Cancer Biotherapy Market Segment by Application
3.1.1 Hospitals
3.1.2 Diagnostic Laboratories
3.1.3 Research and Academic Laboratories
3.1.4 Pharmaceutical and Biotechnology Companies
3.1.5 Others
3.2 Global Cancer Biotherapy Market Size by Application (2017, 2022 & 2028)
3.3 Global Cancer Biotherapy Market Size by Application (2017-2028)
3.4 United States Cancer Biotherapy Market Size by Application (2017, 2022 & 2028)
3.5 United States Cancer Biotherapy Market Size by Application (2017-2028)
4 Global Cancer Biotherapy Competitor Landscape by Company
4.1 Global Cancer Biotherapy Market Size by Company
4.1.1 Top Global Cancer Biotherapy Companies Ranked by Revenue (2021)
4.1.2 Global Cancer Biotherapy Revenue by Player (2017-2022)
4.2 Global Cancer Biotherapy Concentration Ratio (CR)
4.2.1 Cancer Biotherapy Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Cancer Biotherapy in 2021
4.2.3 Global Cancer Biotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Cancer Biotherapy Headquarters, Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million) Type
4.3.1 Global Cancer Biotherapy Headquarters and Area Served
4.3.2 Global Cancer Biotherapy Companies Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Cancer Biotherapy Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Cancer Biotherapy Market Size by Company
4.5.1 Top Cancer Biotherapy Players in United States, Ranked by Revenue (2021)
4.5.2 United States Cancer Biotherapy Revenue by Players (2020, 2021 & 2022)
5 Global Cancer Biotherapy Market Size by Region
5.1 Global Cancer Biotherapy Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Cancer Biotherapy Market Size by Region (2017-2028)
5.2.1 Global Cancer Biotherapy Market Size by Region: 2017-2022
5.2.2 Global Cancer Biotherapy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Cancer Biotherapy Market Size YoY Growth 2017-2028
6.1.2 North America Cancer Biotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Cancer Biotherapy Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Cancer Biotherapy Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Cancer Biotherapy Market Size YoY Growth 2017-2028
6.3.2 Europe Cancer Biotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Cancer Biotherapy Market Size YoY Growth 2017-2028
6.4.2 Latin America Cancer Biotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Cancer Biotherapy Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Cancer Biotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Amgen
7.1.1 Amgen Company Details
7.1.2 Amgen Business Overview
7.1.3 Amgen Cancer Biotherapy Introduction
7.1.4 Amgen Revenue in Cancer Biotherapy Business (2017-2022)
7.1.5 Amgen Recent Development
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Company Details
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Cancer Biotherapy Introduction
7.2.4 Bristol-Myers Squibb Revenue in Cancer Biotherapy Business (2017-2022)
7.2.5 Bristol-Myers Squibb Recent Development
7.3 Celgene
7.3.1 Celgene Company Details
7.3.2 Celgene Business Overview
7.3.3 Celgene Cancer Biotherapy Introduction
7.3.4 Celgene Revenue in Cancer Biotherapy Business (2017-2022)
7.3.5 Celgene Recent Development
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Details
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Cancer Biotherapy Introduction
7.4.4 GlaxoSmithKline Revenue in Cancer Biotherapy Business (2017-2022)
7.4.5 GlaxoSmithKline Recent Development
7.5 Eli Lilly
7.5.1 Eli Lilly Company Details
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Cancer Biotherapy Introduction
7.5.4 Eli Lilly Revenue in Cancer Biotherapy Business (2017-2022)
7.5.5 Eli Lilly Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
    Table 1. Cancer Biotherapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Cancer Biotherapy Market Trends
    Table 3. Cancer Biotherapy Market Drivers
    Table 4. Cancer Biotherapy Market Challenges
    Table 5. Cancer Biotherapy Market Restraints
    Table 6. Global Cancer Biotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cancer Biotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cancer Biotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cancer Biotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cancer Biotherapy Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cancer Biotherapy Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Cancer Biotherapy Revenue Share by Player, 2017-2022
    Table 13. Global Cancer Biotherapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Cancer Biotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biotherapy as of 2021)
    Table 15. Top Players of Cancer Biotherapy in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Cancer Biotherapy Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Cancer Biotherapy Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Cancer Biotherapy Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Cancer Biotherapy Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Cancer Biotherapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Cancer Biotherapy Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Cancer Biotherapy Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Cancer Biotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Cancer Biotherapy Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Cancer Biotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Cancer Biotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Cancer Biotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Amgen Company Details
    Table 31. Amgen Business Overview
    Table 32. Amgen Cancer Biotherapy Product
    Table 33. Amgen Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million)
    Table 34. Amgen Recent Development
    Table 35. Bristol-Myers Squibb Company Details
    Table 36. Bristol-Myers Squibb Business Overview
    Table 37. Bristol-Myers Squibb Cancer Biotherapy Product
    Table 38. Bristol-Myers Squibb Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million)
    Table 39. Bristol-Myers Squibb Recent Development
    Table 40. Celgene Company Details
    Table 41. Celgene Business Overview
    Table 42. Celgene Cancer Biotherapy Product
    Table 43. Celgene Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million)
    Table 44. Celgene Recent Development
    Table 45. GlaxoSmithKline Company Details
    Table 46. GlaxoSmithKline Business Overview
    Table 47. GlaxoSmithKline Cancer Biotherapy Product
    Table 48. GlaxoSmithKline Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million)
    Table 49. GlaxoSmithKline Recent Development
    Table 50. Eli Lilly Company Details
    Table 51. Eli Lilly Business Overview
    Table 52. Eli Lilly Cancer Biotherapy Product
    Table 53. Eli Lilly Revenue in Cancer Biotherapy Business (2017-2022) & (US$ Million)
    Table 54. Eli Lilly Recent Development
    Table 55. Research Programs/Design for This Report
    Table 56. Key Data Information from Secondary Sources
    Table 57. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cancer Biotherapy Product Picture
    Figure 2. Global Cancer Biotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cancer Biotherapy Market Size 2017-2028 (US$ Million)
    Figure 4. United States Cancer Biotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Cancer Biotherapy Market Size 2017-2028 (US$ Million)
    Figure 6. United States Cancer Biotherapy Market Share in Global 2017-2028
    Figure 7. Cancer Biotherapy Report Years Considered
    Figure 8. Product Picture of Monoclonal Antibodies
    Figure 9. Product Picture of Vaccines
    Figure 10. Product Picture of Erythropoietin
    Figure 11. Product Picture of Colony Stimulating Factors
    Figure 12. Product Picture of Interleukins and Interferons
    Figure 13. Global Cancer Biotherapy Market Share by Type in 2022 & 2028
    Figure 14. Global Cancer Biotherapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. Global Cancer Biotherapy Market Share by Type (2017-2028)
    Figure 16. United States Cancer Biotherapy Market Share by Type in 2022 & 2028
    Figure 17. United States Cancer Biotherapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 18. United States Cancer Biotherapy Market Share by Type (2017-2028)
    Figure 19. Product Picture of Hospitals
    Figure 20. Product Picture of Diagnostic Laboratories
    Figure 21. Product Picture of Research and Academic Laboratories
    Figure 22. Product Picture of Pharmaceutical and Biotechnology Companies
    Figure 23. Product Picture of Others
    Figure 24. Global Cancer Biotherapy Market Share by Application in 2022 & 2028
    Figure 25. Global Cancer Biotherapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. Global Cancer Biotherapy Market Share by Application (2017-2028)
    Figure 27. United States Cancer Biotherapy Market Share by Application in 2022 & 2028
    Figure 28. United States Cancer Biotherapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 29. United States Cancer Biotherapy Market Share by Application (2017-2028)
    Figure 30. North America Cancer Biotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. U.S. Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Canada Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Europe Cancer Biotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. Germany Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. France Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. U.K. Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Italy Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Russia Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Asia-Pacific Cancer Biotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 40. China Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Japan Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. South Korea Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. India Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Australia Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Taiwan Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Indonesia Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Thailand Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Malaysia Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Philippines Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Latin America Cancer Biotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Mexico Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Brazil Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Argentina Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Middle East & Africa Cancer Biotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 55. Turkey Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. U.A.E Cancer Biotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Amgen Revenue Growth Rate in Cancer Biotherapy Business (2017-2022)
    Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biotherapy Business (2017-2022)
    Figure 60. Celgene Revenue Growth Rate in Cancer Biotherapy Business (2017-2022)
    Figure 61. GlaxoSmithKline Revenue Growth Rate in Cancer Biotherapy Business (2017-2022)
    Figure 62. Eli Lilly Revenue Growth Rate in Cancer Biotherapy Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4350
This license allows only one user to access the PDF.

Electronic (PDF)
$6525
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$8700
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Kidney Cancer Therapeutics Market Research Report 2022
Global Kidney Cancer Therapeutics Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-4Y11866
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global New Generation Cancer Vaccine Market Research Report 2022
Global New Generation Cancer Vaccine Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-13Z11738
Wed Aug 10 00:00:00 UTC 2022

Add to Cart

Global Cobalt 60 Linear Accelerators Market Research Report 2022
Global Cobalt-60 Linear Accelerators Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-33V11508
Mon Aug 08 00:00:00 UTC 2022

Add to Cart

Global Hodgkin s Lymphoma Therapeutics Market Size Status and Forecast 2021 2027
Global Hodgkin's Lymphoma Therapeutics Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-31N5855
Sun Aug 07 00:00:00 UTC 2022

Add to Cart